SALIOGEN THERAPEUTICS

saliogen-therapeutics-logo

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders. Its Gene Coding approach is guided by our Exact DNA Integration Technology (EDIT) platform, a genome engineering technology that leverages proprietary mammal-derived enzymes they call Saliogase. With broad applicability, non-viral delivery capabilities of any size gene, and significant manufacturing advantages, EDIT has the potential to transform the treatment paradigm for inherited disorders and beyond.

#SimilarOrganizations #People #Financial #Website #More

SALIOGEN THERAPEUTICS

Social Links:

Industry:
Biotechnology Genetics Life Science Therapeutics

Founded:
2020-01-01

Address:
Burlington, Massachusetts, United States

Country:
United States

Website Url:
http://www.saliogen.com

Total Employee:
11+

Status:
Active

Contact:
(650) 906-9468

Total Funding:
135 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Global Site Tag


Similar Organizations

affinia-therapeutics-logo

Affinia Therapeutics

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

parthenon-therapeutics-logo

Parthenon Therapeutics

Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.

ray-therapeutics-logo

Ray Therapeutics

Ray Therapeutics is a biotech company developing optogenetic gene therapies for patients with blinding diseases.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.


Current Advisors List

sean-stalfort_image

Sean Stalfort Board Member @ SalioGen Therapeutics
Board_member

craig-gordon_image

Craig Gordon Board Member @ SalioGen Therapeutics
Board_member
2021-12-01

Current Employees Featured

not_available_image

Joseph Higgins
Joseph Higgins President & Chief Scientific Officer, Founder @ SalioGen Therapeutics
President & Chief Scientific Officer, Founder

sung-you_image

Sung You
Sung You Chief Business and Strategy Officer @ SalioGen Therapeutics
Chief Business and Strategy Officer
2021-07-01

ray-tabibiazar_image

Ray Tabibiazar
Ray Tabibiazar Chairman & CEO @ SalioGen Therapeutics
Chairman & CEO
2021-01-01

Founder


not_available_image

Joseph Higgins

Investors List

symbiosis-ii-llc_image

SymBiosis LLC

SymBiosis LLC investment in Series B - SalioGen Therapeutics

d1-capital-partners_image

D1 Capital Partners

D1 Capital Partners investment in Series B - SalioGen Therapeutics

fidelity-management-and-research-company_image

Fidelity Management and Research Company

Fidelity Management and Research Company investment in Series B - SalioGen Therapeutics

retinal-degeneration-fund_image

Retinal Degeneration Fund

Retinal Degeneration Fund investment in Series B - SalioGen Therapeutics

gordonmd-global-investments_image

GordonMD Global Investments

GordonMD Global Investments investment in Series B - SalioGen Therapeutics

the-cystic-fibrosis-foundation_image

Cystic Fibrosis Foundation

Cystic Fibrosis Foundation investment in Series B - SalioGen Therapeutics

t-rowe-price_image

T. Rowe Price

T. Rowe Price investment in Series B - SalioGen Therapeutics

epiq-capital-group_image

EPIQ Capital Group

EPIQ Capital Group investment in Series B - SalioGen Therapeutics

pbm-capital-group_image

PBM Capital Group

PBM Capital Group investment in Series A - SalioGen Therapeutics

Official Site Inspections

http://www.saliogen.com

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "SalioGen Therapeutics" on Search Engine